BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 7906055)

  • 1. Agmatine: an endogenous clonidine-displacing substance in the brain.
    Li G; Regunathan S; Barrow CJ; Eshraghi J; Cooper R; Reis DJ
    Science; 1994 Feb; 263(5149):966-9. PubMed ID: 7906055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.
    Reis DJ; Li G; Regunathan S
    Ann N Y Acad Sci; 1995 Jul; 763():295-313. PubMed ID: 7677340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Agmatine--an endogenous ligand of imidazoline receptors].
    Kozaeva LP; Korobov NV
    Eksp Klin Farmakol; 2003; 66(5):69-73. PubMed ID: 14650220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter.
    Reis DJ; Regunathan S
    Ann N Y Acad Sci; 1999 Jun; 881():65-80. PubMed ID: 10415899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agmatine--a novel endogenous ligand of imidazoline receptors.
    Herman ZS
    Pol J Pharmacol; 1997; 49(2-3):85-8. PubMed ID: 9437754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and physiological properties of clonidine-displacing substance.
    Atlas D
    Ann N Y Acad Sci; 1995 Jul; 763():314-24. PubMed ID: 7677341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat.
    Sun MK; Regunathan S; Reis DJ
    Clin Exp Hypertens; 1995; 17(1-2):115-28. PubMed ID: 7735262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoline receptors and their endogenous ligands.
    Regunathan S; Reis DJ
    Annu Rev Pharmacol Toxicol; 1996; 36():511-44. PubMed ID: 8725400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla.
    Meeley MP; Ernsberger PR; Granata AR; Reis DJ
    Life Sci; 1986 Mar; 38(12):1119-26. PubMed ID: 3007903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonidine-displacing substance from bovine brain binds to imidazoline receptors and releases catecholamines in adrenal chromaffin cells.
    Regunathan S; Meeley MP; Reis DJ
    Mol Pharmacol; 1991 Dec; 40(6):884-8. PubMed ID: 1758440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction.
    Raasch W; Schäfer U; Qadri F; Dominiak P
    Br J Pharmacol; 2002 Feb; 135(3):663-72. PubMed ID: 11834614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors.
    Holt A; Baker GB
    Prog Brain Res; 1995; 106():187-97. PubMed ID: 8584654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla.
    Regunathan S; Meeley MP; Reis DJ
    Biochem Pharmacol; 1993 Apr; 45(8):1667-75. PubMed ID: 8387303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors.
    Santos WC; Hernández-Guijo JM; Ruiz-Nuño A; Olivares R; Jurkiewicz A; Gandía L; García AG
    Eur J Pharmacol; 2001 Apr; 417(1-2):99-109. PubMed ID: 11301064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozotocin-induced diabetic rats.
    Hwang SL; Liu IM; Tzeng TF; Cheng JT
    Diabetologia; 2005 Apr; 48(4):767-75. PubMed ID: 15756537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agmatine: a novel neurotransmitter?
    Reis DJ; Regunathan S
    Adv Pharmacol; 1998; 42():645-9. PubMed ID: 9327985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agmatine (decarboxylated arginine) is synthesized and stored in astrocytes.
    Regunathan S; Feinstein DL; Raasch W; Reis DJ
    Neuroreport; 1995 Oct; 6(14):1897-900. PubMed ID: 8547593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.